MedTrace Logo

Translating Adoption of Improved Varieties Into Nutritional Impact

NCT02710760 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 978

Last updated 2017-03-09

No results posted yet for this study

Summary

The purposes of this study are (1) to determine whether child nutrition-focused adoption encouragement messages focused on Quality Protein Maize (QPM) and the availability of small quantities of QPM seed can be effective at increasing QPM adoption and health outcomes for young children, and (2) to determine whether consumption encouragement messages and techniques (e.g., containers for earmarking) can be effective at increasing QPM targeting to and health outcomes for young children.

Conditions

  • Malnutrition

Interventions

OTHER

Adoption Encouragement Treatment

Households in the Adoption Encouragement Treatment received child nutrition focused guidance on the nutritional and agronomic benefits of Quality Protein Maize (QPM) adoption, and the opportunity to order up to 6 kg of QPM seed to plant in their own fields.

OTHER

Consumption Encouragement Treatment

Households in the Consumption Encouragement Treatment received the same guidance as households in the Adoption Encouragement Treatment, as well as additional guidance on the importance of specifically targeting foods made with QPM to young children and tools to help households keep the grain separate and remember to feed QPM-based foods to the young children.

Sponsors & Collaborators

  • CIMMYT International Maize and Wheat Improvement Center

    collaborator UNKNOWN

  • Ethiopian Public Health Institute

    collaborator OTHER_GOV

  • Agricultural Technology Adoption Initiative

    collaborator UNKNOWN

  • Harvard School of Public Health (HSPH)

    lead OTHER

Principal Investigators

  • Jessica Cohen, PhD · Harvard Chan School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
6 Months
Max Age
35 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-07-31
Completion
2016-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02710760 on ClinicalTrials.gov